We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$93.4B
1-Year Est. Return
35.25%
This Fund
S&P 500
1 Year Est. Return
+35.25%
AUM
$93.4B
AUM Growth
-$10.4B
(-10%)
Holding
3,278
Top Buys
| 1 | +$3.97B | |
| 2 | +$527M | |
| 3 | +$449M | |
| 4 |
Morgan Stanley
MS
|
+$426M |
| 5 |
Airbnb
ABNB
|
+$367M |
Top Sells
| 1 | +$4.21B | |
| 2 | +$2.87B | |
| 3 | +$831M | |
| 4 |
Amazon
AMZN
|
+$692M |
| 5 |
Eli Lilly
LLY
|
+$641M |
Sector Composition
| 1 | Technology | 21.04% |
| 2 | Consumer Discretionary | 12.43% |
| 3 | Healthcare | 10.52% |
| 4 | Financials | 7.39% |
| 5 | Industrials | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Imperial Petroleum
IMPP
$239M
| $3.45M | ﹤0.01% |
806,621
+777,234
|
|
||
1327
M-tron Industries
MPTI
$411M
| $3.45M | ﹤0.01% |
51,593
+35,999
|
|
||
1328
ICU Medical
ICUI
$3.54B
| $3.45M | ﹤0.01% |
26,687
+25,187
|
|
||
1329
Gain Therapeutics
GANX
$71.7M
| $3.43M | ﹤0.01% |
1,769,788
+107,495
|
|
||
1330
Vertex
VERX
$1.91B
| $3.43M | ﹤0.01% |
288,636
+258,568
|
|
||
1331
Yelp
YELP
$1.26B
| $3.42M | ﹤0.01% |
138,186
-18,565
|
|
||
1332
Liberty Latin America Class A
LILA
$1.6B
| $3.42M | ﹤0.01% |
395,418
+142,900
|
|
||
1333
CorMedix
CRMD
$699M
| $3.42M | ﹤0.01% |
502,965
-1,463,297
|
|
||
1334
Galectin Therapeutics
GALT
$178M
| $3.4M | ﹤0.01% |
1,219,912
+617,778
|
|
||
|
FLNA
1335
Filana Therapeutics
FLNA
$63.3M
| $3.4M | ﹤0.01% |
2,012,543
-102,764
|
|
||
1336
Clarivate
CLVT
$1.37B
| $3.4M | ﹤0.01% |
1,343,271
+337,270
|
|
||
|
NVMI
1337
Nova
NVMI
$18B
| $3.39M | ﹤0.01% |
+7,800
|
|
||
1338
The Greenbrier Companies
GBX
$1.49B
| $3.38M | ﹤0.01% |
+64,246
|
|
||
1339
Stratasys
SSYS
$775M
| $3.36M | ﹤0.01% |
430,695
+149,550
|
|
||
1340
Kura Sushi USA
KRUS
$579M
| $3.35M | ﹤0.01% |
47,982
-12,612
|
|
||
1341
Sylvamo
SLVM
$1.65B
| $3.35M | ﹤0.01% |
79,251
-14,699
|
|
||
1342
TETRA Technologies
TTI
$1.57B
| $3.34M | ﹤0.01% |
392,407
-4,490
|
|
||
|
BIOA
1343
BioAge Labs
BIOA
$736M
| $3.33M | ﹤0.01% |
190,472
-32,476
|
|
||
1344
Structure Therapeutics
GPCR
$3.05B
| $3.33M | ﹤0.01% |
69,107
-99,477
|
|
||
1345
Capricor Therapeutics
CAPR
$1.49B
| $3.33M | ﹤0.01% |
109,531
-12,381
|
|
||
1346
Beam Therapeutics
BEAM
$3.09B
| $3.32M | ﹤0.01% |
139,241
-806,588
|
|
||
1347
Compass Diversified
CODI
$785M
| $3.32M | ﹤0.01% |
421,861
-358,621
|
|
||
1348
Cavco Industries
CVCO
$4.54B
| $3.31M | ﹤0.01% |
6,840
+1,797
|
|
||
1349
Ultragenyx Pharmaceutical
RARE
$2.42B
| $3.3M | ﹤0.01% |
157,526
+85,358
|
|
||
1350
Smith & Wesson
SWBI
$655M
| $3.29M | ﹤0.01% |
229,755
+144,635
|
|